Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Schrodinger Inc
(NQ:
SDGR
)
22.28
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Schrodinger Inc
< Previous
1
2
3
4
Next >
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
September 18, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
September 05, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
August 11, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Second Quarter 2023 Financial Results
August 02, 2023
From
Schrödinger, Inc.
Via
Business Wire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
August 01, 2023
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
July 28, 2023
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Exscientia is the Sniper of the AI Drug Discovery Industry
July 27, 2023
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 20, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce Second Quarter 2023 Financial Results on August 2
July 19, 2023
From
Schrödinger, Inc.
Via
Business Wire
Nvidia Invested $50 million into This AI Drug Discovery Biotech
July 17, 2023
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 22, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Present at Goldman Sachs 44th Annual Global Healthcare Conference
June 01, 2023
From
Schrödinger
Via
Business Wire
Schrödinger to Present at Jefferies Global Biopharma Conference
May 26, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 25, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Strong First Quarter 2023 Financial Results
May 04, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Publishes Inaugural Corporate Sustainability Report
April 27, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger to Announce First Quarter 2023 Financial Results on May 4
April 20, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 19, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 22, 2023
From
Schrödinger, Inc.
Via
Business Wire
MarketBeat Week in Review – 3/6 - 3/10
March 11, 2023
Stocks are down sharply to end the week, and the MarketBeat staff continues to show investors why dividend stocks need to be part of your playbook
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Economy
Interest Rates
Schrodinger is an AI-Powered Drug Discovery Developer to Watch
March 08, 2023
Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results
February 28, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 17, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda
February 14, 2023
From
Schrödinger Inc.
Via
Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28
February 13, 2023
From
Schrödinger
Via
Business Wire
Schrödinger to Present at SVB Securities Global Biopharma Conference
January 31, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 20, 2023
From
Schrödinger
Via
Business Wire
Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities
January 09, 2023
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 16, 2022
From
Schrödinger, Inc.
Via
Business Wire
Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting
December 12, 2022
From
Schrödinger
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.